ACADIA
LIVE

Serial Number

99393415

Owner

Acadia Pharmaceuticals Inc.

Attorney

Carissa L. Weiss

Filing Date

Sep 15, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ACADIA Trademark

Serial Number: 99393415

ACADIA is a trademark filed by Acadia Pharmaceuticals Inc. on September 15, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Acadia Pharmaceuticals Inc.

12830 El Camino Real, Suite 400
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

September 15, 2025

Registration Date

Not Registered

Published for Opposition

September 8, 2026

Goods & Services

Educational services, namely, conducting programs in the field of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders and treatment and patient support options for these conditions

Printed publications, namely, brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information and patient support

Providing on-line non-downloadable software for administering medical benefits and enrolling in benefits patient support program services; Biomedical research services; Industrial research in the field of biotechnology; Scientific research; Scientific and technological services, namely, research and design in the field of biotechnology and biomedicine; Providing scientific research information in the field of biotechnology and biomedicine; Chemical, biochemical, biological and bacteriological research and analysis; Biological research and analysis; Testing of pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research and development; Pharmaceutical research in the field of medical testing, namely, in vitro and in vivo preclinical testing of potential drugs; Providing medical research information in the field of pharmaceuticals

Pharmaceutical preparations for the treatment and prevention of neurologic, rare neurologic, neuropsychiatric, rare neuropsychiatric, metabolic, rare metabolic, genetic, rare genetic, psychologic, rare psychologic, psychiatric, and rare psychiatric diseases and disorders

Promoting awareness of patient support offerings for neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders; Promoting awareness of patient support offerings for pain associated with neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders; Business administration services in the field of healthcare, namely, business administration of reimbursement and medical benefit information for neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions and their treatment; Business administration services in the field of healthcare, namely, business administration of reimbursement and medical benefit information for treatment of pain associated with neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions; Business administrative services for medical referrals

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 8, 2026 NPUB
PUBLISHED FOR OPPOSITION
Sep 8, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 2, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 8, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 29, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 29, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 29, 2026 TROA
ASSIGNED TO EXAMINER
May 4, 2026 DOCK
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 8, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 8, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 9, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 9, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 9, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 9, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 6, 2026 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 15, 2025 MAFR
NEW APPLICATION ENTERED
Sep 15, 2025 NWAP